FR2616333A1 - Procede d'ionophorese pour administrer une substance dissoute ou partiellement dissoute, par voie percutanee ou perungueale et dispositif correspondant - Google Patents

Procede d'ionophorese pour administrer une substance dissoute ou partiellement dissoute, par voie percutanee ou perungueale et dispositif correspondant Download PDF

Info

Publication number
FR2616333A1
FR2616333A1 FR8708182A FR8708182A FR2616333A1 FR 2616333 A1 FR2616333 A1 FR 2616333A1 FR 8708182 A FR8708182 A FR 8708182A FR 8708182 A FR8708182 A FR 8708182A FR 2616333 A1 FR2616333 A1 FR 2616333A1
Authority
FR
France
Prior art keywords
electrode
skin
substance
metal
dissolved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR8708182A
Other languages
English (en)
French (fr)
Inventor
Hans Schaefer
Luc Duteil
Lennart Juhlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Centre International de Recherches Dermatologiques Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre International de Recherches Dermatologiques Galderma filed Critical Centre International de Recherches Dermatologiques Galderma
Priority to FR8708182A priority Critical patent/FR2616333A1/fr
Priority to CH2199/88A priority patent/CH676427A5/fr
Priority to CA000569268A priority patent/CA1315853C/fr
Priority to IT67554/88A priority patent/IT1219374B/it
Priority to GB8813915A priority patent/GB2206493B/en
Publication of FR2616333A1 publication Critical patent/FR2616333A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/0436—Material of the electrode

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Electrotherapy Devices (AREA)
  • Medicinal Preparation (AREA)
FR8708182A 1987-06-12 1987-06-12 Procede d'ionophorese pour administrer une substance dissoute ou partiellement dissoute, par voie percutanee ou perungueale et dispositif correspondant Withdrawn FR2616333A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR8708182A FR2616333A1 (fr) 1987-06-12 1987-06-12 Procede d'ionophorese pour administrer une substance dissoute ou partiellement dissoute, par voie percutanee ou perungueale et dispositif correspondant
CH2199/88A CH676427A5 (enExample) 1987-06-12 1988-06-09
CA000569268A CA1315853C (fr) 1987-06-12 1988-06-10 Procede d'ionophorese pour administrer une substance dissoute ou partiellement dissoute, par voie percutanee ou perungueale et dispositif correspondant
IT67554/88A IT1219374B (it) 1987-06-12 1988-06-10 Dispositivo di ionoforesi per somministrare una sostanza disciolta o parzialmente disciolta per via per cutanea o perungueale
GB8813915A GB2206493B (en) 1987-06-12 1988-06-13 Inophoresis device for the percutaneous or perungual administration of a dissolved or partially dissolved substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8708182A FR2616333A1 (fr) 1987-06-12 1987-06-12 Procede d'ionophorese pour administrer une substance dissoute ou partiellement dissoute, par voie percutanee ou perungueale et dispositif correspondant

Publications (1)

Publication Number Publication Date
FR2616333A1 true FR2616333A1 (fr) 1988-12-16

Family

ID=9351961

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8708182A Withdrawn FR2616333A1 (fr) 1987-06-12 1987-06-12 Procede d'ionophorese pour administrer une substance dissoute ou partiellement dissoute, par voie percutanee ou perungueale et dispositif correspondant

Country Status (5)

Country Link
CA (1) CA1315853C (enExample)
CH (1) CH676427A5 (enExample)
FR (1) FR2616333A1 (enExample)
GB (1) GB2206493B (enExample)
IT (1) IT1219374B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334138A (en) * 1990-03-15 1994-08-02 North Carolina State University Method and composition for increased skin concentration of active agents by iontophoresis
DE4014913C2 (de) * 1990-05-10 1996-05-15 Lohmann Therapie Syst Lts Miniaturisiertes transdermales therapeutisches System für die Iontophorese
US6575957B1 (en) 1990-11-01 2003-06-10 Robert Tapper Iontophoretic treatment system
US5224927A (en) * 1990-11-01 1993-07-06 Robert Tapper Iontophoretic treatment system
US6139537A (en) * 1990-11-01 2000-10-31 Tapper; Robert Iontophoretic treatment system
US6235013B1 (en) 1990-11-01 2001-05-22 Robert Tapper Iontophoretic treatment system
US6238381B1 (en) 1990-11-01 2001-05-29 Robert Tapper Iontophoretic treatment system
US6582416B2 (en) 1990-11-01 2003-06-24 Robert Tapper Iontophoretic treatment system
US6223076B1 (en) 1990-11-01 2001-04-24 Robert Tapper Sweat control system
US5221254A (en) * 1991-04-02 1993-06-22 Alza Corporation Method for reducing sensation in iontophoretic drug delivery
US5131403A (en) * 1991-06-05 1992-07-21 Becton Dickinson And Company Method for obtaining blood using iontophoresis
US5215520A (en) * 1991-09-17 1993-06-01 Centre Internationale De Recherches Dermatologiques Galderma (C.I.R.D. Galderma) Method for delivering an active substance topically or percutaneously
DE4137960A1 (de) * 1991-11-19 1993-05-27 Gerhard Prof Schauf Therapiegeraet zur iontophorese im haut- und schweissdruesenbereich
FR2687321B1 (fr) * 1992-02-14 1999-04-16 Elf Aquitaine Dispositif d'ionophorese pour l'administration transcutanee d'une quantite totale donnee d'un principe actif a un sujet.
GB9404293D0 (en) * 1994-03-04 1994-04-20 Shuster Sam Drug delivery system
DE29700578U1 (de) * 1997-01-15 1997-03-20 Rheinmagnet Horst Baermann GmbH, 53819 Neunkirchen-Seelscheid Pflaster zur transdermalen Applikation von Wirkstoffen
WO2000012172A1 (en) 1998-08-31 2000-03-09 Birch Point Medical Inc. Controlled dosage drug delivery system
US6421561B1 (en) 1999-12-30 2002-07-16 Birch Point Medical, Inc. Rate adjustable drug delivery system
US6653014B2 (en) 2001-05-30 2003-11-25 Birch Point Medical, Inc. Power sources for iontophoretic drug delivery systems
DE10228680A1 (de) * 2002-06-27 2004-01-22 Holden Development Limited, Tortola Grundlage für transdermale Formulierungen (PTF)
US8734421B2 (en) 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
US7480530B2 (en) 2003-06-30 2009-01-20 Johnson & Johnson Consumer Companies, Inc. Device for treatment of barrier membranes
US8150525B2 (en) 2008-08-27 2012-04-03 Johnson & Johnson Consumer Companies, Inc. Treatment of hyperhydrosis
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
AU2010319733B2 (en) 2009-11-13 2014-08-07 Johnson & Johnson Consumer Companies, Inc. Galvanic skin treatment device

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR761853A (fr) * 1932-12-23 1934-03-29 Le Carbone Sa Dispositif avec électrode ionisante pour applications thérapeutiques
FR762259A (fr) * 1933-09-09 1934-04-09 Appareil pour introduire des médicaments dans le corps humain par iontophorèse
FR1570570A (enExample) * 1968-03-28 1969-06-13
FR2509182A1 (fr) * 1981-07-10 1983-01-14 Advance Kk Dispositif d'ionophorese pour applications epidermiques
DE3309841A1 (de) * 1982-11-27 1984-05-30 Nippon Athletic Industry Co., Tokyo Elektrotherapeutische vorrichtung
DE3533230A1 (de) * 1985-09-18 1987-03-26 Ruediger Prof Dr Groening Transdermale arzneiformen mit verbesserter biologischer verfuegbarkeit der wirkstoffe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314554A (en) * 1979-07-16 1982-02-09 Greatbatch W Tissue growth control apparatus and method

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR761853A (fr) * 1932-12-23 1934-03-29 Le Carbone Sa Dispositif avec électrode ionisante pour applications thérapeutiques
FR762259A (fr) * 1933-09-09 1934-04-09 Appareil pour introduire des médicaments dans le corps humain par iontophorèse
FR1570570A (enExample) * 1968-03-28 1969-06-13
FR2509182A1 (fr) * 1981-07-10 1983-01-14 Advance Kk Dispositif d'ionophorese pour applications epidermiques
DE3309841A1 (de) * 1982-11-27 1984-05-30 Nippon Athletic Industry Co., Tokyo Elektrotherapeutische vorrichtung
DE3533230A1 (de) * 1985-09-18 1987-03-26 Ruediger Prof Dr Groening Transdermale arzneiformen mit verbesserter biologischer verfuegbarkeit der wirkstoffe

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CLINICAL AND EXPERIMENTAL DERMATOLOGY, vol. 11, 1986, pages 54-61; M.P. JAMES et al.: "Percutaneous iontophoresis of prednisolone - a pharmacinetic study" *

Also Published As

Publication number Publication date
GB2206493A (en) 1989-01-11
CH676427A5 (enExample) 1991-01-31
GB8813915D0 (en) 1988-07-20
IT1219374B (it) 1990-05-11
GB2206493B (en) 1991-11-13
CA1315853C (fr) 1993-04-06
IT8867554A0 (it) 1988-06-10

Similar Documents

Publication Publication Date Title
FR2616333A1 (fr) Procede d'ionophorese pour administrer une substance dissoute ou partiellement dissoute, par voie percutanee ou perungueale et dispositif correspondant
Phipps et al. Iontophoretic delivery model inorganic and drug ions
EP0612258B1 (en) Drug delivery device
EP0556112B1 (fr) Dispositif d'ionophorèse pour l'administration transcutanée d'une quantité totale donnée d'un principe actif à un sujet
Kalia et al. The electrical characteristics of human skin in vivo
KR101317990B1 (ko) 마이크로전류-발생 국소 또는 미용 시스템, 및 제조 방법 및 그것의 용도
EP0278474A1 (en) Electrolytic transdermal delivery of polypeptides
JPH10512776A (ja) 陰イオン性オリゴ糖類型活性成分の経皮投与のためのイオントフォレーゼ装置
KR20090060279A (ko) 이온 영동 약물 전달 장치를 평가하기 위한 비파괴적 시스템, 장치, 및 방법
US20040167459A1 (en) Methods and systems for controlling and/or increasing iontophoretic flux
JP2003519541A (ja) 競合イオンを用いた選択的薬剤送達プロフィル
Lelawongs et al. Transdermal iontophoretic delivery of arginine-vasopressin (II): Evaluation of electrical and operational factors
Ulbricht et al. After-potentials and large depolarizations of single nodes of Ranvier treated with veratridine
JPS61149168A (ja) イオン導入薬剤供給電極アセンブリ
JP3261501B2 (ja) 改善されたイオン導入法による薬剤投与方法
Banga et al. Characterization of in vitro transdermal iontophoretic delivery of insulin
Singh et al. Transdermal iontophoretic delivery of methylphenidate HCl in vitro
Hirvonen et al. Current profile regulates iontophoretic delivery of amino acids across the skin
Carpenter Electrogenic sodium pump and high specific resistance in nerve cell bodies of the squid
US20190046065A1 (en) Medical Electrode Providing Improved Uniformity of Current Density, Recovery Time and Durability
Numajiri et al. Comparison of depolarizing and direct current systems on iontophoretic enhancement of transport of sodium benzoate through human and hairless rat skin
US20210268275A1 (en) Plate electrodes
Clemessy et al. Preservation of skin permeability during in vitro iontophoretic experiments
FR2895226A1 (fr) Dispositif et procede electrochimiques de mesure de l'etat redox de la peau
EP0778789B1 (fr) Dispositif d'ionophorese pour l'administration transcutanee d'un principe actif a un sujet assurant un controle precis de la posologie

Legal Events

Date Code Title Description
ST Notification of lapse